Publisher Correction: Whole genome sequence analysis of pulmonary function and COPD in 44,287 multi-ancestry participants Authors: Wonji Kim, Xiaowei Hu, Kangjin Kim, Sung Chun, Peter Orchard, Dandi Qiao, Ingo Ruczinski, Aabida Saferali, Francois Aguet, Lucinda Antonacci-Fulton, Pallavi P Balte, Traci M Bartz, Wardatul Jannat Anamika, Xiaobo Zhou, JunYi Duan, Jennifer A Brody, Brian E Cade, Martha L Daviglus, Harshavadran Doddapaneni, Shannon Dugan-Perez, Susan K Dutcher, Christian D Frazar, Stacey B Gabriel, Sina A Gharib, Namrata Gupta, Brian D Hobbs, Silva Kasela, Laura R Loehr, Ginger A Metcalf, Donna M Muzny, Elizabeth C Oelsner, Laura J Rasmussen-Torvik, Colleen M Sitlani, Joshua Smith, Tamar Sofer, Hanfei Xu, Bing Yu, David Zhang, John Ziniti, R Graham Barr Published: 2026 Publisher Correction: Genome Biol 27, 28 (2026) https://doi.org/10.1186/s13059-025-03921-y Following publication of the original article [1], a typesetting error was noticed, whereby the figure legends for figures 1, 2, 3 and 5 were not included in the published article. The figure legends for figures 1, 2, 3 and 5 are given below. The original article [1] has been corrected. Fig. 1 Summary of the multi-ancestry fine-mapping (A) Number of credible sets (CSs) in the 47 significant association regions across all phenotypes and subgroups. (B) Number of variants in 95% level CSs. (C) Distribution of posterior inclusion probability (PIP) by the number of variants in 95% level CSs. X-axis is an ascending ranking of the credible set sizes. Red and blue points represent the maximum and median of PIP in each credible set, respectively. Fig. 2 Comparison of multi-ancestry and European-ancestry fine-mapping (A-C) Box plots for comparing fine-mapping resolution between Multi- and European-ancestry participants in terms of (A) number of fine-mapped variants in credible sets (CSs), (B) genomic interval (kb) of CSs and, (C) maximum posterior inclusion probability (PIP) per CSs. (D) PIP distribution for all variants with PIP > 0.01 in either multi-ancestry or European ancestry fine-mapping analyses (see Supplementary Table 10) (E-F) LocusZoom plots display the improved resolution of fine mapping of a locus near HTR4 with lead variant rs7733410 on FEV1/FVC ratio by including multi-ancestry participants. (E) GWAS and fine mapping results from analysis of all multi-ancestry participants. (F) GWAS and fine mapping results from analysis of all European-ancestry participants. The top row visualizes the strength of association with FEV1/FVC ratio in the target region of HTR4, chr5:148256389-148526959; the bottom row presents fine mapping resolution of association with FEV1/FVC ratio for the same region. Fig. 3 Regional plots of pulmonary trait association and LTRC eQTL for colocalized gene regions. A) ADAM19 for combined analysis of FEV1/FVC ratio. B) C4B for combined analysis of FEV1/FVC ratio. C) THSD4 for combined analysis of FEV1/FVC ratio. D) PSMA4 for COPD-enriched analysis of severe COPD. Each sub-panel presents the genetic association results for a target region; the left plot visualizes the strength of association with pulmonary trait vs LTRC eQTL within the target region; the right top plot shows pulmonary trait association within the target region; and the right bottom plot shows LTRC eQTL association within the target region. The labeled variant is the lead variant identified from the sum of P-values for pulmonary trait association and LTRC eQTL, and other variants are colored according to their LD R2 with the lead variant. The TOPMed Freeze 8 genotype data of 1,360 LTRC samples were used to calculate in-sample LD for LTRC colocalization and for generating plots. Fig. 5 Overview of the statistical modeling workflow. We illustrate a workflow for (A) the single variant-based association analysis and (B) the variant set-based association analysis. Footnotes Wonji Kim, Xiaowei Hu and Kangjin Kim contributed equally to this work. Ani Manichaikul and Michael H. Cho jointly supervised this work. Contributor Information Ani Manichaikul, Email: amanicha@virginia.edu. Michael H. Cho, Email: remhc@channing.harvard.edu Reference